54
Participants
Start Date
January 1, 2024
Primary Completion Date
December 30, 2027
Study Completion Date
December 30, 2027
Venetoclax : 100mg on day 1, 200mg on day 2, 400mg on days 3 to 8; oral administration;
Induction Phase Regimen
Venetoclax (Venetoclax): 400mg on day 1 to day 7; oral administration;
Consolidation therapy after remission
utologous stem cell transplantation (ASCT) /allogeneic hematopoietic stem cell transplantation (allo-HSCT).
Four cycles in total.Patients who meet the criteria for autologous stem cell transplantation (ASCT) during the treatment process can undergo ASCT.Patients who meet the transplantation criteria and have a suitable donor can undergo allogeneic hematopoietic stem cell transplantation (allo-HSCT).
RECRUITING
The First Affiliated Hospital with Nanjing Medical University, Nanjing
Huai'an First People's Hospital
OTHER
Yancheng First People's Hospital
OTHER
The First Affiliated Hospital with Nanjing Medical University
OTHER